To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"Once the animals were put on the drug, we were able to reverse the disease after a single month with no adverse side effects?while they ate a high-fat diet."

(Jupiter, FL) - Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.

The compound - known as SR9238 - is the first to effectively suppress lipid or fat production in the liver, eliminating inflammation and reversing fat accumulation in animal models of fatty liver disease. The new compound also significantly lowered total cholesterol levels, although precisely how that occurred remains something of a mystery.

"We've been working on a pair of natural proteins called LXRa and LXRB that stimulate fat production in the liver, and we thought our compound might be able to successfully suppress this process," said Thomas Burris, a professor at TSRI who led the study, which was recently published in an online edition of the journal ACS Chemical Biology. (Photo courtesy: The Scripps Research Institute)

"Once the animals were put on the drug, we were able to reverse the disease after a single month with no adverse side effects - while they ate a high-fat diet."

Fatty liver, which often accompanies obesity and type 2 diabetes, frequently leads to more serious conditions including cirrhosis and liver cancer. The condition affects some 10 to 24 percent of the general population, according to a 2003 study in GUT, an international journal of gastroenterology and hepatology.

Burris and his colleagues designed SR9238 so that it would be quickly metabolized in the liver to minimize migration of the drug into the bloodstream, which could lead to side effects.

In the study, mice were fed a high-fat diet for 14 weeks prior to treatment with SR9238. After one month of treatment, the scientists found that the liver's fat-producing genes were repressed and fat expression in the liver was reduced up to 90 percent.

In addition, the scientists observed an 80 percent reduction of the enzyme responsible for producing cholesterol (3-Hydroxy-3-methylglutaryl coenzyme A Reductase) - the same enzyme targeted by statins.

Markers for liver damage were down as well, which suggests the compound may also have the potential to treat alcohol-related fatty liver damage.

The first author of the study, "A Liver Selective LXR Inverse Agonist that Suppresses Hepatic Steatosis" is Kristine Griffett of TSRI. Other authors include Laura A. Solt, Bahaa El-Dien M. El-Gendy and Theodore M. Kamenecka, also of TSRI.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

America Reads the Bible' Kicks Off in DC in Record-Breaking Fashion

Sweden Rethinks Digital Learning, Returns to 'Old-Fashioned' Books in Effort to Reverse Poor Literacy

Supreme Court Rejects Parents' Challenge to Massachusetts School Trans Policy

Gay Couple Face Online Fury for Video Making Fun of Crying Baby: 'There Is No Mama'

The Electoral College and the Popular Vote

The DOJ Has Found HOW MANY Dead People on Voter Rolls?

President Donald Trump to Read Scripture during America Reads the Bible; Issues Historic Message About the Bible's 'Enduring Guidance'

US Military Boards Iranian Ship in Gulf; Trump Threatens No More 'Mr. Nice Guy' if Talks Fail

Long Beach, California Cancels Their Popular July 4th Fireworks Show, Even for America's 250th Birthday, Citing Pollution as the Reason

Digital Nightmare? Anthropic Withholds AI Model Too Dangerous for Humanity

'A Victory for All Pro-Life Oregonians': Federal Judge Rules State Can't Force Oregon Right to Life to Pay for Abortions

10 Republicans Side With Dems to Provide Amnesty to Haitian Illegals

Virginia Dems Pass National Popular Vote Law that Experts Warn Is Unconstitutional

Israel-Lebanon Ceasefire Begins; Trump Says Iran's Regime Agrees to Give Up Having Nuclear Weapons

President Trump: Strait of Hormuz 'Fully Open', Oil Prices Drop

Clarence Thomas Destroys 'Progressivism' in Ruthless Speech

Trump Reveals He Has Multi-Pick SCOTUS Plan Ready as Justice Retirement Speculation Heats Up

Trump Admin Pushes Global Plan to Protect Kids Online

Youth Mental Health Deteriorates after Gender Reassignment Services, Extensive, Long-Term Study Finds

Trump Administration Pulls $11 Million in Funding for Catholic Charities that Sheltered Illegal Alien Minors

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor